Literature DB >> 33530466

Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair.

Hsuan Peng1, Kazuhiro Shindo1, Renée R Donahue1, Ahmed Abdel-Latif1.   

Abstract

Stem cell-based cardiac therapies have been extensively studied in recent years. However, the efficacy of cell delivery, engraftment, and differentiation post-transplant remain continuous challenges and represent opportunities to further refine our current strategies. Despite limited long-term cardiac retention, stem cell treatment leads to sustained cardiac benefit following myocardial infarction (MI). This review summarizes the current knowledge on stem cell based cardiac immunomodulation by highlighting the cellular and molecular mechanisms of different immune responses to mesenchymal stem cells (MSCs) and their secretory factors. This review also addresses the clinical evidence in the field.

Entities:  

Keywords:  heart failure; inflammation; mesenchymal stem cells; myocardial infarction; stem cell therapy

Mesh:

Year:  2021        PMID: 33530466      PMCID: PMC7865339          DOI: 10.3390/ijms22031201

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  96 in total

1.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

2.  Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial.

Authors:  Emerson C Perin; Ricardo Sanz-Ruiz; Pedro L Sánchez; José Lasso; Rosa Pérez-Cano; Juan C Alonso-Farto; Esther Pérez-David; Maria Eugenia Fernández-Santos; Patrick W Serruys; Henrick J Duckers; Jens Kastrup; Steven Chamuleau; Yi Zheng; Guilherme V Silva; James T Willerson; Francisco Fernández-Avilés
Journal:  Am Heart J       Date:  2014-04-05       Impact factor: 4.749

Review 3.  Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review.

Authors:  Patricia K Nguyen; June-Wha Rhee; Joseph C Wu
Journal:  JAMA Cardiol       Date:  2016-10-01       Impact factor: 14.676

4.  Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

Authors:  Chui-Yee Fong; Li-Ling Chak; Arijit Biswas; Jee-Hian Tan; Kalamegam Gauthaman; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

5.  Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

Authors:  Jozef Bartunek; Atta Behfar; Dariouch Dolatabadi; Marc Vanderheyden; Miodrag Ostojic; Jo Dens; Badih El Nakadi; Marko Banovic; Branko Beleslin; Mathias Vrolix; Victor Legrand; Christian Vrints; Jean Louis Vanoverschelde; Ruben Crespo-Diaz; Christian Homsy; Michal Tendera; Scott Waldman; William Wijns; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

Review 6.  Abandoning M1/M2 for a Network Model of Macrophage Function.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2016-07-22       Impact factor: 17.367

7.  Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).

Authors:  Anders Bruun Mathiasen; Abbas Ali Qayyum; Erik Jørgensen; Steffen Helqvist; Anne Fischer-Nielsen; Klaus F Kofoed; Mandana Haack-Sørensen; Annette Ekblond; Jens Kastrup
Journal:  Eur Heart J       Date:  2015-04-29       Impact factor: 29.983

Review 8.  The Role of Macrophages in the Infarcted Myocardium: Orchestrators of ECM Remodeling.

Authors:  Sinead A O'Rourke; Aisling Dunne; Michael G Monaghan
Journal:  Front Cardiovasc Med       Date:  2019-07-31

9.  c-kit+ cells minimally contribute cardiomyocytes to the heart.

Authors:  Jop H van Berlo; Onur Kanisicak; Marjorie Maillet; Ronald J Vagnozzi; Jason Karch; Suh-Chin J Lin; Ryan C Middleton; Eduardo Marbán; Jeffery D Molkentin
Journal:  Nature       Date:  2014-05-07       Impact factor: 49.962

Review 10.  The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.

Authors:  Yajun Guo; Yunsheng Yu; Yueqiu Chen; Shijun Hu; Zhenya Shen
Journal:  Cell Death Dis       Date:  2020-05-11       Impact factor: 8.469

View more
  4 in total

Review 1.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

Review 2.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

Review 3.  Mass Customized Outlook for Regenerative Heart Failure Care.

Authors:  Satsuki Yamada; Jozef Bartunek; Atta Behfar; Andre Terzic
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

4.  Fibrin, Bone Marrow Cells and Macrophages Interactively Modulate Cardiomyoblast Fate.

Authors:  Inês Borrego; Aurélien Frobert; Guillaume Ajalbert; Jérémy Valentin; Cyrielle Kaltenrieder; Benoît Fellay; Michael Stumpe; Stéphane Cook; Joern Dengjel; Marie-Noëlle Giraud
Journal:  Biomedicines       Date:  2022-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.